JACC Journals

jaccjournals.bsky.social

16 October 2026 15:02

The 2026 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction is here! What’s new in #HFpEF management? Read here: https://bit.ly/4hu2fdb #JACC #CardioSky

deprescribing.org

deprescribing.bsky.social

02 October 2026 19:09

Find our benzodiazepine and Z-drug deprescribing resources below. Our focus is to review the potentially inappropriate long-term use of benzodiazepines or Z-drugs for insomnia 💤: buff.ly/Qw2tJOL Visit buff.ly/Ie5yYva for non-pharmacological alternatives to benzodiazepines for sleep.

The Lancet

thelancet.com

02 October 2026 15:22

Peripheral arterial disease (PAD) affects more than 300 million people worldwide—yet it remains under-recognised, underdiagnosed, and undertreated. A new Editorial discusses a Lancet Series aiming to address this major health burden: spkl.io/633207pL2I

NEJM.org

nejm.org

01 October 2026 17:44

The STAREE trial tested whether atorvastatin prevents first major cardiovascular events and extends disability-free survival in adults 70 years and older without cardiovascular disease. Research findings are summarized in a new Quick Take video. https://nej.md/4xXoFIG #ESCCongress

CADeN | ReCAD

caden-recad.bsky.social

30 September 2026 11:08

We have a problem with overprescribing—what if annual medication reviews became the norm? In @ledevoir.com, our Network Director @dremilymcd.bsky.social discusses the 🇨🇦 guideline on potentially inappropriate prescribing & the importance of regularly reassessing meds. 👉 tinyurl.com/532kvvbb